Page last updated: 2024-11-05

tetrabutylammonium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetrabutylammonium (TBA) is a quaternary ammonium cation with the chemical formula [N(C4H9)4]+. It is a colorless, hygroscopic solid that is commonly used as a counterion in organic synthesis and electrochemistry. It is typically synthesized by the reaction of tributylamine with butyl bromide. Tetrabutylammonium salts are used as phase-transfer catalysts, facilitating reactions between organic and inorganic compounds in two-phase systems. They are also employed as electrolytes in electrochemical applications, such as battery research and organic synthesis, due to their high conductivity and electrochemical stability. The study of TBA and its salts is driven by their diverse applications in various fields, including synthesis, catalysis, electrochemistry, and material science.'

tetrabutylammonium: lipophilic probe; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16028
CHEMBL ID1236196
CHEBI ID45825
SCHEMBL ID22384
MeSH IDM0054060

Synonyms (40)

Synonym
tetrabuthylammonium
CHEMBL1236196 ,
tetrabutylammonium ion
inchi=1/c16h36n/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4/h5-16h2,1-4h3/q+
DB01851
10549-76-5
n,n,n-tributylbutan-1-aminium
tetrabutylammonium
CHEBI:45825 ,
tetrabutylazanium
AKOS002258926
1-butanaminium, n,n,n-tributyl-
unii-cbu2x6bbjr
cbu2x6bbjr ,
bdbm50416487
AB00444480-02
bu4n+
tetra-n-butyl ammonium
tetrabutyammonium
tetra-butylammonium
tetra-butyl ammonium
tetra(n-butyl)ammonium
tetra (n-butyl) ammonium
tetra butyl-ammonium
DZLFLBLQUQXARW-UHFFFAOYSA-N
tetrabutyl ammonium
SCHEMBL22384
tetrabutylammonium ion(1+)
tetrabutylammonium cation
tetra-n-butylammonium
ammonium, tetrabutyl-
tetrabutylammonium(1+)
DTXSID3045011
taa4
tetrabutyl-ammonium
NCGC00334822-01
FT-0755282
2-(4-bromophenyl)-propanedioicacid1,3-bis-t-butylester
Q27092979
STL194044

Research Excerpts

Overview

Tetrabutylammonium is a phase-transfer agent commonly used in PET radiochemistry.

ExcerptReferenceRelevance
"Tetrabutylammonium is a phase-transfer agent commonly used in PET radiochemistry. "( Tetrabutylammonium HPLC analysis: shortcomings in the Ph. Eur. method.
Bogni, A; Cucchi, C; Laera, L; Pascali, C; Seregni, E, 2020
)
3.44

Effects

ExcerptReferenceRelevance
"Tetrabutylammonium fluoride has been found to catalyze the deacylation of cellulose esters. "( TBAF and cellulose esters: unexpected deacylation with unexpected regioselectivity.
Edgar, KJ; Xu, D, 2012
)
1.82

Treatment

ExcerptReferenceRelevance
"Pretreatment with tetrabutylammonium concentration dependently reduced the endothelium-dependent relaxation induced by acetylcholine, cyclopiazonic acid and ionomycin."( Inhibitory effect of tetrabutylammonium ions on endothelium/nitric oxide-mediated vasorelaxation.
Bourreau, JP; Chan, HY; Huang, Y; Lau, CW; Wong, JW; Yao, X, 2001
)
0.95

Toxicity

ExcerptReferenceRelevance
" In the present study, the acute toxic effect of PFOA in the absence and presence of either chromium (III) or tetra butyl ammonium (TBA) towards Pseudomonas putida in the aquatic environment was investigated by microcalorimetry."( Toxicity of perfluorooctanoic acid to Pseudomonas putida in the aquatic environment.
Cai, M; Chen, H; Liu, H; Wang, F; Yao, J, 2013
)
0.39

Compound-Compound Interactions

ExcerptReferenceRelevance
"A solid-phase extraction method combined with deep eutectic solvent-based dispersive liquid-liquid microextraction has been developed for the extraction of three antibiotics in honey samples prior to their determination by ion mobility spectrometry."( Preparation of multiwall carbon nanotube/urea-formaldehyde nanocomposite as a new sorbent in solid-phase extraction and its combination with deep eutectic solvent-based dispersive liquid-liquid microextraction for extraction of antibiotic residues in hone
Afshar Mogaddam, MR; Javadi, A; Mirzaei, H; Nemati, M; Shahi, M, 2021
)
0.62

Dosage Studied

ExcerptRelevanceReference
" It is concluded that water-soluble deliquescent substances, normally encountered in pharmaceutical dosage forms, rapidly form saturated aqueous solutions in the aqueous film formed as water vapor uptake proceeds, and that the water uptake rate can be predicted a priori from known and experimentally determinable parameters using the heat transport model."( Moisture sorption kinetics for water-soluble substances. IV: Studies with mixtures of solids.
Kontny, MJ; Zografi, G, 1985
)
0.27
" The assay was applied to the analysis of the four bisphosphonic acids in commercial dosage formulations, in which the excipients did not interfere with the determination."( A sensitive post-column photochemical derivatization/fluorimetric detection system for HPLC determination of bisphosphonates.
García-Martínez, MD; Martínez-Lozano, C; Pérez-Ruiz, T, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quaternary ammonium ionA derivative of ammonium, NH4(+), in which all four of the hydrogens bonded to nitrogen have been replaced with univalent (usually organyl) groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 1Mus musculus (house mouse)Ki7.30003.60005.45007.3000AID682044
Solute carrier family 22 member 2Homo sapiens (human)IC50 (µMol)120.00000.40003.10009.7000AID679160
Solute carrier family 22 member 1 Homo sapiens (human)IC50 (µMol)52.00000.21005.553710.0000AID679154
Solute carrier family 22 member 1 Homo sapiens (human)Ki29.60000.55004.26507.4600AID679156
Solute carrier family 22 member 1Rattus norvegicus (Norway rat)IC50 (µMol)5.45000.18003.68578.8000AID679212; AID681348
Solute carrier family 22 member 1Rattus norvegicus (Norway rat)Ki17.00000.13002.37856.9000AID678997
Solute carrier family 22 member 2Rattus norvegicus (Norway rat)IC50 (µMol)5.70001.00004.446710.0000AID681345
Solute carrier family 22 member 2Rattus norvegicus (Norway rat)Ki12.00000.39002.32959.4000AID681633
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier family 22 member 1Mus musculus (house mouse)Km43.000010.000010.000010.0000AID680371
Solute carrier family 22 member 1 Homo sapiens (human)Activity6.50000.71005.30179.7000AID681117
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (42)

Processvia Protein(s)Taxonomy
activation of cysteine-type endopeptidase activity involved in apoptotic processSolute carrier family 22 member 2Homo sapiens (human)
positive regulation of gene expressionSolute carrier family 22 member 2Homo sapiens (human)
organic cation transportSolute carrier family 22 member 2Homo sapiens (human)
monoatomic cation transportSolute carrier family 22 member 2Homo sapiens (human)
neurotransmitter transportSolute carrier family 22 member 2Homo sapiens (human)
serotonin transportSolute carrier family 22 member 2Homo sapiens (human)
body fluid secretionSolute carrier family 22 member 2Homo sapiens (human)
organic cation transportSolute carrier family 22 member 2Homo sapiens (human)
quaternary ammonium group transportSolute carrier family 22 member 2Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 2Homo sapiens (human)
amine transportSolute carrier family 22 member 2Homo sapiens (human)
putrescine transportSolute carrier family 22 member 2Homo sapiens (human)
spermidine transportSolute carrier family 22 member 2Homo sapiens (human)
acetylcholine transportSolute carrier family 22 member 2Homo sapiens (human)
choline transportSolute carrier family 22 member 2Homo sapiens (human)
dopamine transportSolute carrier family 22 member 2Homo sapiens (human)
norepinephrine transportSolute carrier family 22 member 2Homo sapiens (human)
xenobiotic transportSolute carrier family 22 member 2Homo sapiens (human)
epinephrine transportSolute carrier family 22 member 2Homo sapiens (human)
histamine transportSolute carrier family 22 member 2Homo sapiens (human)
serotonin uptakeSolute carrier family 22 member 2Homo sapiens (human)
histamine uptakeSolute carrier family 22 member 2Homo sapiens (human)
norepinephrine uptakeSolute carrier family 22 member 2Homo sapiens (human)
thiamine transmembrane transportSolute carrier family 22 member 2Homo sapiens (human)
purine-containing compound transmembrane transportSolute carrier family 22 member 2Homo sapiens (human)
amino acid import across plasma membraneSolute carrier family 22 member 2Homo sapiens (human)
dopamine uptakeSolute carrier family 22 member 2Homo sapiens (human)
L-arginine import across plasma membraneSolute carrier family 22 member 2Homo sapiens (human)
export across plasma membraneSolute carrier family 22 member 2Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 22 member 2Homo sapiens (human)
L-alpha-amino acid transmembrane transportSolute carrier family 22 member 2Homo sapiens (human)
spermidine transmembrane transportSolute carrier family 22 member 2Homo sapiens (human)
L-arginine transmembrane transportSolute carrier family 22 member 2Homo sapiens (human)
cellular detoxificationSolute carrier family 22 member 2Homo sapiens (human)
xenobiotic transport across blood-brain barrierSolute carrier family 22 member 2Homo sapiens (human)
xenobiotic metabolic processSolute carrier family 22 member 1 Homo sapiens (human)
neurotransmitter transportSolute carrier family 22 member 1 Homo sapiens (human)
serotonin transportSolute carrier family 22 member 1 Homo sapiens (human)
establishment or maintenance of transmembrane electrochemical gradientSolute carrier family 22 member 1 Homo sapiens (human)
organic cation transportSolute carrier family 22 member 1 Homo sapiens (human)
quaternary ammonium group transportSolute carrier family 22 member 1 Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 1 Homo sapiens (human)
monoamine transportSolute carrier family 22 member 1 Homo sapiens (human)
putrescine transportSolute carrier family 22 member 1 Homo sapiens (human)
spermidine transportSolute carrier family 22 member 1 Homo sapiens (human)
acetylcholine transportSolute carrier family 22 member 1 Homo sapiens (human)
dopamine transportSolute carrier family 22 member 1 Homo sapiens (human)
norepinephrine transportSolute carrier family 22 member 1 Homo sapiens (human)
thiamine transportSolute carrier family 22 member 1 Homo sapiens (human)
xenobiotic transportSolute carrier family 22 member 1 Homo sapiens (human)
epinephrine transportSolute carrier family 22 member 1 Homo sapiens (human)
serotonin uptakeSolute carrier family 22 member 1 Homo sapiens (human)
norepinephrine uptakeSolute carrier family 22 member 1 Homo sapiens (human)
thiamine transmembrane transportSolute carrier family 22 member 1 Homo sapiens (human)
metanephric proximal tubule developmentSolute carrier family 22 member 1 Homo sapiens (human)
purine-containing compound transmembrane transportSolute carrier family 22 member 1 Homo sapiens (human)
dopamine uptakeSolute carrier family 22 member 1 Homo sapiens (human)
monoatomic cation transmembrane transportSolute carrier family 22 member 1 Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 22 member 1 Homo sapiens (human)
(R)-carnitine transmembrane transportSolute carrier family 22 member 1 Homo sapiens (human)
acyl carnitine transmembrane transportSolute carrier family 22 member 1 Homo sapiens (human)
spermidine transmembrane transportSolute carrier family 22 member 1 Homo sapiens (human)
cellular detoxificationSolute carrier family 22 member 1 Homo sapiens (human)
xenobiotic transport across blood-brain barrierSolute carrier family 22 member 1 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (24)

Processvia Protein(s)Taxonomy
amine transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
acetylcholine transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
neurotransmitter transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
monoamine transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
organic cation transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
L-amino acid transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
pyrimidine nucleoside transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
choline transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
thiamine transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
putrescine transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
efflux transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
spermidine transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
quaternary ammonium group transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
toxin transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
xenobiotic transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
L-arginine transmembrane transporter activitySolute carrier family 22 member 2Homo sapiens (human)
acetylcholine transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
neurotransmitter transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
dopamine:sodium symporter activitySolute carrier family 22 member 1 Homo sapiens (human)
norepinephrine:sodium symporter activitySolute carrier family 22 member 1 Homo sapiens (human)
protein bindingSolute carrier family 22 member 1 Homo sapiens (human)
monoamine transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
secondary active organic cation transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
organic cation transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
pyrimidine nucleoside transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
thiamine transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
putrescine transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
spermidine transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
quaternary ammonium group transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
toxin transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
identical protein bindingSolute carrier family 22 member 1 Homo sapiens (human)
xenobiotic transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
(R)-carnitine transmembrane transporter activitySolute carrier family 22 member 1 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
plasma membraneSolute carrier family 22 member 2Homo sapiens (human)
basal plasma membraneSolute carrier family 22 member 2Homo sapiens (human)
membraneSolute carrier family 22 member 2Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 2Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 2Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 2Homo sapiens (human)
presynapseSolute carrier family 22 member 2Homo sapiens (human)
plasma membraneSolute carrier family 22 member 1 Homo sapiens (human)
basal plasma membraneSolute carrier family 22 member 1 Homo sapiens (human)
membraneSolute carrier family 22 member 1 Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 1 Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 1 Homo sapiens (human)
lateral plasma membraneSolute carrier family 22 member 1 Homo sapiens (human)
presynapseSolute carrier family 22 member 1 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID681345TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT2-expressing MDCK cells2001Pharmaceutical research, Nov, Volume: 18, Issue:11
Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.
AID679160TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in Xenopus laevis oocytes2002Pharmaceutical research, Aug, Volume: 19, Issue:8
Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2).
AID679154TP_TRANSPORTER: inhibition of TEA uptake (TEA: 10 uM) in OCT1-expressing HeLa cells1999The Journal of pharmacology and experimental therapeutics, Mar, Volume: 288, Issue:3
The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1.
AID681348TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT1-expressing MDCK cells2001Pharmaceutical research, Nov, Volume: 18, Issue:11
Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.
AID681117TP_TRANSPORTER: inhibition of TEA uptake in OCT1-expressing HeLa cells2003Molecular pharmacology, Mar, Volume: 63, Issue:3
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.
AID1576479Antimalarial activity against Plasmodium falciparum infected in erythrocytes in presence of 1 uM pantothenic acid by SYBR safe-based fluorescence assay2019MedChemComm, Dec-01, Volume: 10, Issue:12
Overcoming synthetic challenges in targeting coenzyme A biosynthesis with the antimicrobial natural product CJ-15,801.
AID679212TP_TRANSPORTER: inhibition of TEA uptake (TEA: 10 uM) in Xenopus laevis oocytes1999Molecular pharmacology, Dec, Volume: 56, Issue:6
Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate.
AID682044TP_TRANSPORTER: inhibition of MPP+ uptake in Xenopus laevis oocytes2000The Journal of pharmacology and experimental therapeutics, Mar, Volume: 292, Issue:3
Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
AID678997TP_TRANSPORTER: inhibition of MPP+ uptake in Xenopus laevis oocytes2000The Journal of pharmacology and experimental therapeutics, Mar, Volume: 292, Issue:3
Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
AID679156TP_TRANSPORTER: inhibition of MPP+ uptake in Xenopus laevis oocytes2000The Journal of pharmacology and experimental therapeutics, Mar, Volume: 292, Issue:3
Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1).
AID681633TP_TRANSPORTER: inhibition of TEA uptake (electrogenicity) in Xenopus laevis oocytes2001American journal of physiology. Renal physiology, Sep, Volume: 281, Issue:3
Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.
AID680371TP_TRANSPORTER: uptake in Oct1-expressing BALB/3T3 cells2000Journal of lipid research, Nov, Volume: 41, Issue:11
Functional expression of a high affinity mammalian hepatic choline/organic cation transporter.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (531)

TimeframeStudies, This Drug (%)All Drugs %
pre-199033 (6.21)18.7374
1990's92 (17.33)18.2507
2000's170 (32.02)29.6817
2010's203 (38.23)24.3611
2020's33 (6.21)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.55 (24.57)
Research Supply Index6.29 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index97.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (0.74%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other534 (99.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]